Cabot (NYSE:CBT) Announces Quarterly Earnings Results, Beats Estimates By $0.06 EPS

Cabot (NYSE:CBT) released its quarterly earnings results on Monday. The specialty chemicals company reported $1.61 earnings per share for the quarter, topping analysts’ consensus estimates of $1.55 by $0.06, FiscalAI reports. Cabot had a return on equity of 19.79% and a net margin of 5.69%. The firm had revenue of $1.01 billion during the quarter, compared to analysts’ expectations of $927.29 million. During the same quarter in the prior year, the business earned $1.70 EPS. Cabot’s quarterly revenue was up 12.2% compared to the same quarter last year.

Cabot Stock Performance

Cabot stock opened at $72.00 on Wednesday. The stock has a market cap of $3.72 billion, a P/E ratio of 17.96, a price-to-earnings-growth ratio of 8.91 and a beta of 0.83. The company has a current ratio of 1.47, a quick ratio of 0.97 and a debt-to-equity ratio of 0.48. The stock has a 50 day moving average of $77.55 and a 200-day moving average of $79.52. Cabot has a 52 week low of $58.33 and a 52 week high of $94.53.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on CBT shares. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cabot in a report on Friday, August 21st. Wall Street Zen upgraded shares of Cabot from a “hold” rating to a “buy” rating in a report on Sunday, October 11th. JPMorgan Chase & Co. upped their price objective on shares of Cabot from $70.00 to $78.00 and gave the company an “underweight” rating in a research report on Friday, August 7th. UBS Group decreased their price objective on shares of Cabot from $92.00 to $86.00 and set a “neutral” rating for the company in a research report on Monday, October 5th. Finally, Truist Financial set a $100.00 target price on Cabot in a research note on Wednesday, August 5th. Two analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Cabot has an average rating of “Hold” and an average target price of $87.80.

Key Headlines Impacting Cabot

Here are the key news stories impacting Cabot this week:

• Positive Sentiment: Fourth-quarter adjusted EPS was $1.61, above the $1.55 consensus, while revenue of about $1.01 billion topped estimates of roughly $927 million and rose 12.2% year over year. Cabot beats Q4 earnings and revenue estimates
• Positive Sentiment: Cabot reported $43 million in fiscal-year EBITDA from Battery Materials and secured a $50 million U.S. Department of Energy grant to expand domestic production of battery conductive additives. These developments support its growth ambitions in battery materials. Cabot fiscal 2026 results
• Neutral Sentiment: Fiscal 2026 operating cash flow of $421 million funded $207 million in capital investments, $97 million in dividends and $146 million in share repurchases, demonstrating cash generation and shareholder returns. Cabot fiscal 2026 results
• Negative Sentiment: Cabot forecast fiscal 2027 adjusted EPS of $6.15–$6.75, below the $7.03 analyst consensus. The company also expects $200–$230 million in capital spending. The below-consensus outlook is a key headwind for the stock. Cabot fiscal 2027 guidance
• Negative Sentiment: Despite the quarterly beat, adjusted EPS fell from $1.70 a year earlier, and coverage cited weaker margins. Fiscal 2026 adjusted EPS also declined to $6.42 from $7.25, adding to concerns about profitability. Cabot falls despite earnings beat

Insider Buying and Selling at Cabot

In related news, CEO Sean Keohane sold 134,895 shares of Cabot stock in a transaction on Friday, August 28th. The shares were sold at an average price of $85.00, for a total value of $11,466,075.00. Following the completion of the sale, the chief executive officer owned 404,134 shares in the company, valued at approximately $34,351,390. The trade was a 25.03% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders have sold a total of 229,597 shares of company stock worth $19,646,746 over the last three months. 3.08% of the stock is currently owned by company insiders.

Cabot Company Profile

Cabot Corporation (NYSE: CBT) is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company develops and manufactures materials used to improve the performance, durability, conductivity, color and purity of products across a range of industries.

Cabot’s products include carbon black used in tires, rubber goods, coatings, plastics and printing inks; specialty carbons and conductive materials for batteries and other applications; and specialty compounds and masterbatches.